These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38494133)

  • 21. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
    Vélez-Pastrana MC; González RA; Ramos-Fernández A; Ramírez Padilla RR; Levin FR; Albizu García C
    Eur Addict Res; 2020; 26(4-5):179-190. PubMed ID: 32615575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temperament in Adulthood Attention Deficit-Hyperactivity Disorder without Bipolar Disorder.
    Ozdemiroglu F; Karakus K; Memis CO; Sevincok L; Mersin S
    Psychiatry Investig; 2018 Mar; 15(3):266-271. PubMed ID: 29475238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affective temperaments and self-harm in adolescents: a cross-sectional study from a community sample.
    Guerreiro DF; Sampaio D; Rihmer Z; Gonda X; Figueira ML
    J Affect Disord; 2013 Dec; 151(3):891-8. PubMed ID: 24035491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Objective assessment of motor activity in a clinical sample of adults with attention-deficit/hyperactivity disorder and/or cyclothymic temperament.
    Syrstad VEG; Mjeldheim K; Førland W; Jakobsen P; Gjestad R; Berle JØ; Merikangas KR; Oedegaard KJ; Fasmer OB
    BMC Psychiatry; 2022 Sep; 22(1):609. PubMed ID: 36104774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic liability to ADHD and substance use disorders in individuals with ADHD.
    Wimberley T; Agerbo E; Horsdal HT; Ottosen C; Brikell I; Als TD; Demontis D; Børglum AD; Nordentoft M; Mors O; Werge T; Hougaard D; Bybjerg-Grauholm J; Hansen MB; Mortensen PB; Thapar A; Riglin L; Langley K; Dalsgaard S
    Addiction; 2020 Jul; 115(7):1368-1377. PubMed ID: 31803957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Korean Validation of the Short Version of the TEMPS-A (Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire) in Patients with Mood Disorders.
    Choi S; Yu H; Yoon J; Jang Y; Lee D; Park YS; Ihm HK; Ryoo HA; Cho N; Woo JM; Kang HS; Ha TH; Myung W
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring Personality and Readiness to Change in Patients With Substance Use Disorders With and Without ADHD.
    Flores-García L; Ytterstad E; Lensing MB; Eisemann M
    J Atten Disord; 2020 Jul; 24(9):1255-1265. PubMed ID: 27866153
    [No Abstract]   [Full Text] [Related]  

  • 28. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population.
    van de Glind G; Van Emmerik-van Oortmerssen K; Carpentier PJ; Levin FR; Koeter MW; Barta C; Kaye S; Skutle A; Franck J; Konstenius M; Bu ET; Moggi F; Dom G; Demetrovics Z; Fatséas M; Schillinger A; Kapitány-Fövény M; Verspreet S; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Allsop S; Carruthers S; Schoevers RA; ; van den Brink W
    Int J Methods Psychiatr Res; 2013 Sep; 22(3):232-44. PubMed ID: 24022983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
    Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
    Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study.
    Flores-García L; Lensing MB; Ytterstad E; Eisemann M
    Atten Defic Hyperact Disord; 2019 Sep; 11(3):299-310. PubMed ID: 30903585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.
    Kronenberg LM; Slager-Visscher K; Goossens PJ; van den Brink W; van Achterberg T
    BMC Psychiatry; 2014 Sep; 14():264. PubMed ID: 25234344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships Among Delayed Sleep Phase Disorder, Emotional Dysregulation, and Affective Temperaments in Adults With Attention Deficit Hyperactivity Disorder and Cyclothymia.
    Quaranta G; Barbuti M; Pallucchini A; Colombini P; Moriconi M; Gemmellaro T; Tripodi B; Palagini L; Schiavi E; Perugi G
    J Nerv Ment Dis; 2020 Nov; 208(11):857-862. PubMed ID: 32769692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Past Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder on Substance Use Disorder.
    Coetzee C; Schellekens AFA; Truter I; Meyer A
    Eur Addict Res; 2023; 29(1):9-18. PubMed ID: 36349763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronotype is associated with affective temperaments, clinical severity and worse treatment outcomes in bipolar disorders: results from a two-center, cross-sectional study.
    Menculini G; Steardo LJ; Verdolini N; D'Angelo M; Chipi E; Cirimbilli F; Orsolini L; Volpe U; De Fazio P; Tortorella A
    Int J Psychiatry Clin Pract; 2023 Sep; 27(3):248-256. PubMed ID: 36622183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
    Wilens TE; Kwon A; Tanguay S; Chase R; Moore H; Faraone SV; Biederman J
    Am J Addict; 2005; 14(4):319-27. PubMed ID: 16188712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of affective temperaments in bipolar disorder: The solid role of the cyclothymic, the contentious role of the hyperthymic, and the neglected role of the irritable temperaments.
    Karam EG; Saab D; Jabbour S; Karam GE; Hantouche E; Angst J
    Eur Psychiatry; 2023 Apr; 66(1):e37. PubMed ID: 37092353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity Disorder.
    González RA; Vélez-Pastrana MC; Blankers M; Bäcker A; Konstenius M; Holtmann M; Levin FR; Noack M; Kaye S; Demetrovics Z; van de Glind G; van den Brink W; Schellekens A;
    Eur Addict Res; 2020; 26(4-5):211-222. PubMed ID: 32594079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
    Brynte C; Aeschlimann M; Barta C; Begeman AHA; Bäcker A; Crunelle CL; Daigre C; De Fuentes-Merillas L; Demetrovics Z; Dom G; López LG; Icick R; Johnson B; Joostens P; Kapitány-Fövény M; Karsinti E; Kiefer F; Konstenius M; Levin FR; Luderer M; Markus W; Matthys F; Moggi F; Palma-Alvarez RF; Paraskevopoulou M; Ramos-Quiroga JA; Schellekens A; Soravia LM; Therribout N; Thomas A; van de Glind G; van Kernebeek MW; Vollstädt-Klein S; Vorspan F; van den Brink W; Franck J
    BMC Psychiatry; 2022 Sep; 22(1):625. PubMed ID: 36151539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.
    Wilens TE; Biederman J
    J Psychopharmacol; 2006 Jul; 20(4):580-8. PubMed ID: 16174669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.